Effect of Different Interferonα2 Preparations on IP10 and ET-1 Release from Human Lung Cells

BACKGROUND: Alfa-interferons (IFNα2a, IFNα2b, 40KDa-PEGIFNα2a and 12KDa-PEGIFNα2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumonitis and pulmonary arterial hypertension. Although r...

Descripción completa

Detalles Bibliográficos
Autores principales: Badiger, Rekha, Mitchell, Jane A., Gashaw, Hime, Galloway-Phillipps, Neil A., Foser, Stefan, Tatsch, Fernando, Singer, Thomas, Hansel, Trevor T., Manigold, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466308/
https://www.ncbi.nlm.nih.gov/pubmed/23056449
http://dx.doi.org/10.1371/journal.pone.0046779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466308/
https://www.ncbi.nlm.nih.gov/pubmed/23056449
http://dx.doi.org/10.1371/journal.pone.0046779

Ejemplares similares